The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity.

Its scope is:

arrow Interaction with authorities regarding immunogenicity guidelines

arrow Formulate active recommendations regarding immunogenicity

arrow Stimulate research addressing the clinical and non-clinical effects of unwanted immunogenicity

arrowCollaboration between academia and pharmaceutical companies,

The European Immunogenicity Platform aims to build a broad knowledge-base related to immunogenicity, and to stimulate interactions and developments in the broad field of immunogenicity.

Through its working-group structure, the EIP can react in a focused way on regulatory and scientific evolutions in the immunogenicity-field. The European Immunogenicity Platform was created early 2007 by experts in the field of immunogenicity.

 

More information available herearrow_yellow